An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Incyte to Present at Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Incyte (Nasdaq:INCY) will present at the Goldman Sachs Annual Healthcare CEOs Unscripted Conference on January 4, 2024, and at the 42nd Annual J. P. Morgan Healthcare Conference on January 8, 2024. The presentations will be webcast live and can be accessed at Investor.Incyte.com.
Positive
None.
Negative
None.
WILMINGTON, Del.--(BUSINESS WIRE)--
Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of January:
Goldman Sachs Annual Healthcare CEOs Unscripted Conference: A View from the Top on Thursday, January 4, 2024 at 9:30 am (EST)
42nd Annual J. P. Morgan Healthcare Conference on Monday, January 8, 2024 at 7:30 am (PST)
The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay.
About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
What conferences will Incyte (Nasdaq:INCY) present at in January 2024?
Incyte (Nasdaq:INCY) will present at the Goldman Sachs Annual Healthcare CEOs Unscripted Conference on January 4, 2024, and at the 42nd Annual J. P. Morgan Healthcare Conference on January 8, 2024.
Where can I access the live webcast of Incyte's presentations?
The presentations will be webcast live and can be accessed at Investor.Incyte.com.
How can I access the replay of Incyte's presentations?
The presentations will be available for replay at Investor.Incyte.com.
incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. our vision is to become a leader in the development and delivery of novel drugs for serious unmet medical needs. we have established multiple collaborations with major pharmaceutical companies to support the clinical development and global commercialization of several of our compounds. the incyte corporate headquarters is located in wilmington, delaware, and more than 625 employees comprise our experienced management, discovery, clinical development and commercial teams. our assets, experience and prior success in bringing important new drugs to market put us in a strong position to make a difference by improving the lives of patients and building sustainable value for our shareholders. for more information about incyte, please visit our corporate website at www.incyte.com.
